AbbVie eyes $10B US expansion amid sector-specific tariff threat
AbbVie CEO Rob Michael said the company will invest $10 billion in the US over the next decade, as the threat of pharmaceutical-specific tariffs looms. AbbVie announced plans in its first-quarter earnings to add four ...
AbbVie CEO Rob Michael said the company will invest $10 billion in the US over the next decade, as the threat of pharmaceutical-specific tariffs looms.
AbbVie announced plans in its first-quarter earnings to add four ...
